Despite this, within the NRTI group, individuals receiving tenofovir/emtricitabine had the shortest mean relative TL, although this did not reach statistical significance.
1
—
—
Despite this, within the NRTI group, individuals receiving tenofovir/emtricitabine had the shortest mean relative TL, although this did not reach statistical significance.